Advantagene is a clinical-stage biotech developing a Gene-Mediated Cytotoxic Immunotherapy (GMCI) platform, running a ProstAtak Phase 3 prostate cancer registration trial and advancing brain, lung, pancreatic oncology programs.
Highlights
No Highlights Available
This company doesn't have industry or investor information available.
